Haosen Pharmaceuticals has developed into a modern and innovative pharmaceutical group integrating chemical and biological drug research
Haosen Pharmaceuticals has developed into a modern and innovative pharmaceutical group integrating chemical and biological drug research, pharmaceutical intermediates and API synthesis, preparation manufacturing and product sales. It is a national key high-tech enterprise, one of the top 20 of China's top 100 pharmaceutical enterprises, and one of the main R&D and production bases of anti-tumor and psychotropic drugs in China.
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchReal Estate, Industrials, Financials
Tech for Global, Globalization Footprints of the Established and the New
Dada group's revenue rose nearly 30% in the third quarter, and JD's "hour purchase" cont
Looking forward to the fourth quarter of 2021, dada Group expects its total revenue to be between 2 billion yuan and 2.1 billion yuan. On the premise that the last kilometer of dada express delivery service is consistent with the comparable basis, the total revenue in the fourth quarter of 2021 will achieve a year-on-year increase of 88% to 97%.
Nov 24, 2021 11:42 AM